Yüklüyor......
Targeting the cancer kinome through polypharmacology
Kinase inhibitors are the largest class of new cancer drugs. However, it is already apparent that most tumours can escape from the inhibition of any single kinase. If it is necessary to inhibit multiple kinases, how do we choose which ones? In this Opinion article, we discuss some of the strategies...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2880454/ https://ncbi.nlm.nih.gov/pubmed/20094047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc2787 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|